National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

About | Ordering | New

Menu menu

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$43.00
add to cart

Rights & Permissions

topleft topright

Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health (2006)
Board on Science, Technology, and Economic Policy (STEP)

Citation Manager

. "Front Matter." Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health. Washington, DC: The National Academies Press, 2006.

Please select a format:

BibTeX EndNote RefMan
Page
XV
bottomleft bottomright
  E-mail
Share on facebook Facebook
Share on delicious Delicious
Share on stumbleupon Stumble
Share on twitter Twitter
More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health

List of Boxes, Figures, and Tables

BOXES

A

  

Patenting the Oncomouse,

  

23

B

  

Birth of the Biotechnology Industry,

  

47

C

  

Summary of Principles of the International Strategy Meeting on Human Genome Sequencing,

  

57

FIGURES

4-1

  

Number of DNA-based U.S. patents (as of June 30, 2005),

  

103

4-2

  

Thirty entities holding the largest number of DNA-based U.S. patents (as of June 30, 2005),

  

104

4-3

  

DNA patent trends, 1995-2004,

  

107

4-4

  

Protein structure patent trends, 1995-2004,

  

108

4-5

  

Protein-protein interactions patent trends, 1995-2004,

  

108

4-6

  

Research tools patent trends, 1995-2004,

  

109

4-7

  

Molecular pathway patent trends, 1995-2004,

  

109

4-8

  

Patent class 536/23.1 (DNA/RNA fragments) application pendency by quarter, 1997-2002,

  

112

4-9

  

DNA patents: inventor and assignee country, 1995-2004,

  

113

4-10

  

Protein patents: inventor and assignee country, 1995-2004,

  

113

4-11

  

Research tools patents: inventor and assignee country, 1995-2004,

  

114

4-12

  

Molecular pathway patents: inventor and assignee country, 1995-2004,

  

114

4-13

  

Patterns of university licensing of DNA inventions by company type,

  

118
Page
XV